We are live on ! Find out more
HBIO icon

Harvard Bioscience
HBIO

79 hedge funds and large institutions have $82.4M invested in Harvard Bioscience in 2013 Q2 according to their latest regulatory filings, with 79 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

2,620% more call options, than puts

Call options by funds: $136K | Put options by funds: $5K

Holders
79
Holders Change
+79
Holders Change %
–
% of All Funds
2.58%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.03%
New
79
Increased
–
Reduced
–
Closed
–
Calls
$136K
Puts
$5K
Net Calls
+$131K
Net Calls Change
+$131K

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
BIT
1
BlackRock Institutional Trust
California
$10.4M +$11.1M +290,575 New
Fidelity Investments
2
Fidelity Investments
Massachusetts
$7.13M +$7.61M +198,854 New
Dimensional Fund Advisors
3
Dimensional Fund Advisors
Texas
$7.1M +$7.58M +197,940 New
FCAM
4
F&C Asset Management
United Kingdom
$5.65M +$6.07M +158,480 New
HSA
5
Hussman Strategic Advisors
Maryland
$4.73M +$5.05M +131,900 New
GIM
6
Granahan Investment Management
Massachusetts
$4.61M +$4.95M +129,302 New
Vanguard Group
7
Vanguard Group
Pennsylvania
$3.98M +$4.25M +111,088 New
RA
8
Royce & Associates
New York
$3.63M +$3.87M +101,180 New
BFA
9
BlackRock Fund Advisors
California
$3.17M +$3.41M +88,982 New
PAIM
10
Punch & Associates Investment Management
Minnesota
$2.15M +$2.31M +60,351 New
BA
11
Bard Associates
Illinois
$1.93M +$2.08M +54,260 New
Fuller & Thaler Asset Management
12
Fuller & Thaler Asset Management
California
$1.86M +$2M +52,285 New
Morgan Stanley
13
Morgan Stanley
New York
$1.83M +$1.97M +51,392 New
Renaissance Technologies
14
Renaissance Technologies
New York
$1.73M +$1.86M +48,671 New
State Street
15
State Street
Massachusetts
$1.7M +$1.82M +47,420 New
Northern Trust
16
Northern Trust
Illinois
$1.68M +$1.81M +47,235 New
HMC
17
Harbert Management Corporation
Alabama
$1.57M +$1.68M +43,791 New
MOACM
18
Mutual of America Capital Management
New York
$1.5M +$1.6M +41,708 New
CSM
19
Central Square Management
Illinois
$1.33M +$1.43M +37,265 New
BA
20
BlackRock Advisors
Delaware
$1.25M +$1.35M +35,184 New
USAA
21
United Services Automobile Association
Texas
$1.07M +$1.14M +29,843 New
Acadian Asset Management
22
Acadian Asset Management
Massachusetts
$947K +$1.02M +26,565 New
BCM
23
Bridgeway Capital Management
Texas
$939K +$1.01M +26,356 New
GCP
24
GSA Capital Partners
United Kingdom
$716K +$769K +20,088 New
Bank of New York Mellon
25
Bank of New York Mellon
New York
$701K +$754K +19,703 New
1
2 3 4

HBIO Hedge Fund Activity: Q2 2013 in Review

79 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in Harvard Bioscience (HBIO) for Q2 2013, worth a combined $82.4M.

Buyers outnumbered sellers: 79 funds opened new HBIO positions and 0 closed out — a net gain of 79 holders — while 0 added to existing stakes and 0 trimmed.

  • 79 institutional investors held Harvard Bioscience (HBIO) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $82.4M of Harvard Bioscience stock for Q2 2013.
  • 79 funds opened new Harvard Bioscience positions in Q2 2013 and 0 closed out, a net change of +79 holders.

Based on aggregated 13F filings for Q2 2013.